Skip to main content
Year archive

Vivesto — 2021 filings

All 29 regulatory filings released by Vivesto (VIVE) in 2021, sourced directly from the official regulator.

29 Filings
2021 Period
2021 filings (29)
Filing Released Lang
Valberedning utsedd inför Oasmias årsstämma 2022
AGM Information
2021-12-02 Swedish
Nomination Committee appointed for the 2022 Annual General Meeting in Oasmia
AGM Information
2021-12-02 English
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-18 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-18 English
Bulletin from Extraordinary General Meeting in Oasmia Pharmaceutical AB
AGM Information
2021-10-21 English
Kommuniké från extra bolagsstämma i Oasmia Pharmaceutical AB
AGM Information
2021-10-21 Swedish
Oasmia announces global settlement of all disputes with MGC Capital, former Board Members of Oasmia and members of former management
Regulatory Filings
2021-10-21 English
Oasmia har träffat en allomfattande uppgörelse av samtliga tvister med MGC Capital, Oasmias tidigare styrelse samt dess tidigare ledning
Legal Proceedings Report
2021-10-21 Swedish
Notice of Extraordinary General Meeting in Oasmia Pharmaceutical AB
AGM Information
2021-09-20 English
Kallelse till extra bolagsstämma i Oasmia Pharmaceutical AB
AGM Information
2021-09-20 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report H2 2021
2021-08-19 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-08-19 English
Report from Annual General Meeting in Oasmia Pharmaceutical AB
AGM Information
2021-05-27 English
Kommuniké från årsstämma i Oasmia Pharmaceutical AB
AGM Information
2021-05-27 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-05-27 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-05-27 English
Annual Report 2020
Annual Report H2 2020
2021-04-29 Swedish
Annual Report 2020
Annual Report FY 2020
2021-04-29 English
Notice of Annual General Meeting in Oasmia Pharmaceutical AB
AGM Information
2021-04-27 English
Kallelse till årsstämma i Oasmia Pharmaceutical AB
AGM Information
2021-04-27 Swedish
The Nomination Committee of Oasmia proposes Andrea Buscaglia as new Board member
Board/Management Information
2021-04-27 English
Oasmias valberedning föreslår Andrea Buscaglia som ny styrelseledamot
Board/Management Information
2021-04-27 Swedish
Oasmias vinner rätten att registrera patent i eget namn och tilldelas fullständiga rättegångskostnader
Legal Proceedings Report
2021-03-24 Swedish
Oasmia wins sole rights to record patents in its own name and is awarded full legal costs
Legal Proceedings Report
2021-03-24 English
Oasmia förvärvar globala rättigheter för utveckling och kommersialisering av Cantrixil - ett kliniskt program inom äggstockscancer
M&A Activity
2021-03-01 Swedish
Oasmia acquires global development and commercialization rights for Cantrixil, a clinical stage, ovarian cancer program
Capital/Financing Update
2021-03-01 English
Regulatory Filings 2021
Regulatory Filings
2021-02-19 English
Earnings Release 2020
Earnings Release Q3 2020
2021-02-19 Swedish
Earnings Release 2020
Earnings Release FY 2020
2021-02-19 English